ZHANG Dan 张丹

Mr. Zhang Dan

• Foreign academician of Russian Academy of Engineering, co-founder and co-chairman of Hillgene Biology

• Doctor of Medicine, Peking Union Medical College; Master of Public Health, Harvard University; Master of Management, Wharton School, University of Pennsylvania

• Director of China Pharmaceutical Innovation Promotion Association, Vice Chairman of Innovation Research and Development Service Committee

• Responsible expert of the national “13th Five-Year Plan” major New drug development plan

• Head of ICHE19 IFPMA Expert Committee, expert of NMPA ICH Working Group.

• Chief scientist of Xingwan Biology, co-founder of Kunling Medicine, former first chairman of Quintiles Greater China, senior CRO industry entrepreneur and entrepreneur

• Successful approval of domestic and foreign innovative drugs leading dozens of innovative drugs